🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mariann Polgar‐Turcsanyi

Brigham and Women's Hospital

ORCID: 0000-0002-1244-1802

Also affiliated with Harvard University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis”.

Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis

Neurology Neuroimmunology & Neuroinflammation(2022)10.1212/nxi.0000000000200052
N/A
0DataRank · unranked
171 citations

Brian C. Healy, Yanqing Liu, Shrishti Saxena, Anu Paul, Mariann Polgar‐Turcsanyi +6 more

Challenges to Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple Sclerosis

Multiple Sclerosis and Related Disorders(2022)10.1016/j.msard.2022.103793
N/A
0DataRank · unranked
9 citations

Arpita Gopal, Valerie J. Block, Anne M. Suskind, Chao Zhao, Mariann Polgar‐Turcsanyi +11 more

Multiple sclerosis lesions that impair memory map to a connected memory circuit

Journal of Neurology(2023)10.1007/s00415-023-11907-8
N/A
0DataRank · unranked
16 citations

Alexander L. Cohen, Bonnie I. Glanz, Michael A. Ferguson, Shahamat Tauhid, Jing Li +10 more

Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study

Journal of Neuroinflammation(2023)10.1186/s12974-023-02816-8
N/A
0DataRank · unranked
15 citations

Gauruv Bose, Hrishikesh Lokhande, Shrishti Saxena, Brian C. Healy, Mariann Polgar‐Turcsanyi +3 more

miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod

Journal of Neuroinflammation(2023)10.1186/s12974-023-02811-z
N/A
0DataRank · unranked
9 citations

Rohit Patel, Brian C. Healy, Hrishikesh Lokhande, Anu Paul, Shrishti Saxena +4 more

Effect of Early Treatment Intensity on Progression Independent of Relapse Activity and Disability Accumulation in Multiple Sclerosis

medRxiv(2025)10.1101/2025.07.18.25331653
N/A
0DataRank · unranked
0 citations

Negar Molazedeh, Mariann Polgar‐Turcsanyi, Tanuja Chitnis, Jessica Ye